HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Charron, P Articles by Komajda, M Search for Related Content PubMed PubMed Citation Articles by Charron, P Articles by Komajda, M

Danon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey

^2,

¹ Département de Génétique, Cytogénétique et Embryologie, Hôpital Pitié-Salpêtrière, Paris, France
² INSERM, U621, Paris, France
³ Institut de Myologie, Hôpital Pitié-Salpêtrière, Paris, France
⁴ Service de Génétique, Hôpital Rouen, Rouen, France
⁵ Service de Biochimie, Hôpital Pitié-Salpêtrière, Paris, France

Correspondence to:
Correspondence to:
Dr Philippe Charron
Département de Génétique, Batiment Babinski, Hôpital Pitié-Salpêtrière, 47 Blvd de l’Hôpital, 75856 Cedex 13, Paris, France; pcharron{at}infobiogen.fr

Background: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease caused by mutations in sarcomeric genes. However, extensive genetic screening failed to identify a mutation in about a third of cases. One possible explanation is that other diseases, caused by other genes, may mimic HCM.

Objective: To investigate the possible involvement of Danon’s disease, an X linked lysosomal disease, in a large population of patients with HCM.

Methods: A population of 197 index cases was considered; 124 were subsequently excluded because of a mutation in sarcomeric genes and 23 because of autosomal dominant inheritance. Fifty index cases were therefore included in molecular analysis (direct sequencing) of the lysosome associated membrane protein 2 (LAMP2) gene responsible for Danon’s disease.

Results: Two new mutations leading to premature stop codons were identified in patients who evolved towards severe heart failure (< 25 years old): 657C>T and 173_179del. The prevalence was therefore 1% of the total population (two of 197) or 4% of enrolled index cases (two of 50). Interestingly, Danon’s disease was responsible for half of the cases (two of four) with HCM and clinical skeletal myopathy but was not involved in isolated HCM (none of 41).

Conclusions: Danon’s disease may be involved in patients with previously diagnosed as HCM. A diagnosis strategy is proposed. To distinguish HCM from Danon’s disease is important because the clinical evolution, prognosis, mode of inheritance, and therefore genetic counselling are very different.

Abbreviations: CK, creatine kinase; HCM, hypertrophic cardiomyopathy; IQ, intelligence quotient; LAMP2, lysosome associated membrane protein 2; PRKAG2, 2 subunit of AMP activated protein kinase

Keywords: gene; hypertrophic cardiomyopathy; Danon’s disease; LAMP2; lysosome associated membrane protein 2; skeletal myopathy

This article has been cited by other articles:

				S. D. Colan, S. E. Lipshultz, A. M. Lowe, L. A. Sleeper, J. Messere, G. F. Cox, P. R. Lurie, E. J. Orav, and J. A. Towbin Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry Circulation, February 13, 2007; 115(6): 773 - 781. [Abstract] [Full Text] [PDF]

				P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF]

				M. Fanin, A. C. Nascimbeni, L. Fulizio, M. Spinazzi, P. Melacini, and C. Angelini Generalized Lysosome-Associated Membrane Protein-2 Defect Explains Multisystem Clinical Involvement and Allows Leukocyte Diagnostic Screening in Danon Disease Am. J. Pathol., April 1, 2006; 168(4): 1309 - 1320. [Abstract] [Full Text] [PDF]

				Z. Yang, C. J. McMahon, L. R. Smith, J. Bersola, A. M. Adesina, J. P. Breinholt, D. L. Kearney, W. J. Dreyer, S. W. Denfield, J. F. Price, et al. Danon Disease as an Underrecognized Cause of Hypertrophic Cardiomyopathy in Children Circulation, September 13, 2005; 112(11): 1612 - 1617. [Abstract] [Full Text] [PDF]

				P Charron, E Villard, P Sebillon, P Laforet, T Maisonobe, L Duboscq-Bidot, N Romero, V Drouin-Garraud, T Frebourg, P Richard, et al. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey J. Med. Genet., October 1, 2004; 41(10): 751 - 751. [Full Text] [PDF]